Volume 3 Supplement 1
Rational, computer-aided design of multi-target ligands
© Achenbach and Proschak; licensee BioMed Central Ltd. 2011
Published: 19 April 2011
Over the past two decades the “one drug – one target – one disease” concept became the prevalent paradigm in drug discovery. The main idea of this approach is the identification of a single protein target whose inhibition leads to a successful treatment of the examined disease. The predominant assumption is that highly selective ligands would avoid unwanted side effects caused by binding to secondary non-therapeutic targets.
In recent years the results of post-genomic and network biology showed that proteins rarely act in isolated systems but rather as a part of a highly connected network . In addition this connectivity leads to more robust systems that cannot be interfered by the inhibition of a single target of that network and consequently might not lead to the desired therapeutic effect . Furthermore studies prove that robust systems are rather affected by weak inhibitions of several parts than by a complete inhibition of a single selected element of that system .
Therefore there is an increasing interest in developing drugs that take effect on multiple targets simultaneously but is concurrently a great challenge for medicinal chemists. There has to be a sufficient activity on each target as well as an adequate pharmacokinetic profile . Early design strategies tried to link the pharmacophors of known inhibitors, however these methods often lead to high molecular weight and low ligand efficacy.
We present a new rational approach based on a retrosynthetic combinatorial analysis procedure  on approved ligands of multiple targets. These RECAP fragments are used to design a large combinatorial library containing molecules featuring chemical properties of each ligand class. The molecules are further validated by machine learning models, like random forests and self-organizing maps, regarding their activity on the targets of interest.
- Jeong H, Mason SP, Barabási AL, Oltvai ZN: Lethality and centrality in protein networks. Nature. 2001, 411: 41-42. 10.1038/35075138.View ArticleGoogle Scholar
- Kitano H: Towards a theory of biological robustness. Molecular Systems Biology. 2007, 3: 137-10.1038/msb4100179.View ArticleGoogle Scholar
- Agoston V, Csermely P, Pongor S: Multiple weak hits confuse complex systems: a transcriptional regulatory network as an example. Phys Rev E. 2005, 71: 051909-10.1103/PhysRevE.71.051909.View ArticleGoogle Scholar
- Morphy R, Rankovic Z: Designing multiple ligands - medicinal chemistry strategies and challenges. Curr Pharm Design. 2009, 15: 587-600. 10.2174/138161209787315594.View ArticleGoogle Scholar
- Lewell XQ, Judd DB, Watson SP, Hann MM: RECAP - retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J Chem Inf Comput Sci. 1998, 18: 511-522.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.